Compare JFIN & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JFIN | MBOT |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.7M | 73.2M |
| IPO Year | 2018 | 2000 |
| Metric | JFIN | MBOT |
|---|---|---|
| Price | $1.44 | $0.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | 591.0K | ★ 836.4K |
| Earning Date | 11-27-2026 | 11-27-2026 |
| Dividend Yield | ★ 58.39% | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $377.83 |
| P/E Ratio | $1.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.13 | $0.93 |
| 52 Week High | $8.83 | $2.86 |
| Indicator | JFIN | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 42.39 | 24.79 |
| Support Level | $1.21 | N/A |
| Resistance Level | $1.43 | $1.18 |
| Average True Range (ATR) | 0.16 | 0.09 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 14.85 | 18.97 |
Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.